King Luther Capital Management Corp Lowers Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

King Luther Capital Management Corp lessened its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,504 shares of the exchange traded fund’s stock after selling 130 shares during the period. King Luther Capital Management Corp’s holdings in SPDR S&P Biotech ETF were worth $445,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the stock. Fifth Third Bancorp grew its position in SPDR S&P Biotech ETF by 3.4% in the second quarter. Fifth Third Bancorp now owns 118,303 shares of the exchange traded fund’s stock worth $10,968,000 after acquiring an additional 3,922 shares in the last quarter. PFG Investments LLC increased its position in shares of SPDR S&P Biotech ETF by 9.2% during the 2nd quarter. PFG Investments LLC now owns 24,844 shares of the exchange traded fund’s stock valued at $2,303,000 after purchasing an additional 2,097 shares during the last quarter. IFG Advisory LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at about $241,000. Beaton Management Co. Inc. bought a new stake in SPDR S&P Biotech ETF in the 3rd quarter worth approximately $212,000. Finally, Atria Wealth Solutions Inc. boosted its stake in SPDR S&P Biotech ETF by 56.1% in the second quarter. Atria Wealth Solutions Inc. now owns 16,597 shares of the exchange traded fund’s stock worth $1,539,000 after buying an additional 5,962 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

XBI stock opened at $96.24 on Friday. The company has a market capitalization of $7.34 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a one year low of $71.99 and a one year high of $105.47. The company’s 50 day moving average price is $98.44 and its two-hundred day moving average price is $96.27.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.